Skip to main content
. 2014 Apr 8;56(4):376–381. doi: 10.1097/JOM.0000000000000137

TABLE 4.

Change in Percent Predicted Spirometry Parameters for an Interquartile Change in Urinary Phthalate Metabolite Concentrations by Age*

Age 6–16 (n = 1642) Age 17–49 (n = 1505)
Urinary Phthalate FEV1 FVC FEV1/FVC FEV1 FVC FEV1/FVC
MnBP −0.5 (−1.3, 0.3) −0.9 (−1.6, −0.1) 0.9 (−0.7, 2.6) −0.8 (−1.7, 0.2) −0.6 (−1.5, 0.2) −0.3 (−1.0, 0.4)
MBzP −0.6 (−1.5, 0.3) −0.7 (−1.6, 0.2) 0.0 (−0.5, 0.5) −0.5 (−1.5, 0.6) 0.4 (−0.6, 1.4) −0.8 (−1.4, −0.2)
MCPP −3.9 (−6.3, −1.4) −1.0 (−1.8, −0.2) −3.0 (−4.7, −1.4) −0.8 (−1.7, 0.1) −0.7 (−1.6, 0.2) −0.2 (−0.8, 0.4)
MEP −0.6 (−2.5, 1.3) −0.8 (−2.1, 1.8) −0.3 (−0.9, 0.3) −0.7 (−1.5, 0.1) −1.0 (−1.7, −0.3) 0.2 (−0.4, 0.8)
ΣDEHP −0.3 (−1.2,0.6) 0.4 (−0.2, 0.9) −0.7 (−1.6, 0.1) −0.9 (−1.6, −0.2) −0.8 (−1.5, −0.1) −1.0 (−1.8, −0.2)

*Results are adjusted for PM2.5, sex, smoking (current, occasional, and nonsmokers), fasting, income, and education. Italicized data show results considered statistically significant if 95% confidence limits do not encompass 0.

DEHP, di(2-ethylhexyl) phthalate; FEV1, 1-second forced expiratory volume; FVC, forced vital capacity; MBzP, mono-benzyl phthalate; MCPP, mono-3-carboxypropyl phthalate; MEP, mono-ethyl phthalate; MnBP, mono-n-butyl phthalate.